<?xml version="1.0" encoding="UTF-8"?>
<p>Fungal infections can be either superficial or invasive [
 <xref rid="B81-molecules-26-00628" ref-type="bibr">81</xref>]. Treating human fungal infections mainly involves the use of oral tablets or topicals creams. It is also more difficult to apply treatment for fungal infections than bacterial, because human and fungal cells share the commonality of being eukaryotic. If the fungal treatment targets and acts against a common structure in eukaryotic cells, this may also lead to toxicity for the human cells, compromising host safety [
 <xref rid="B81-molecules-26-00628" ref-type="bibr">81</xref>]. When developing an antifungal drug, it is important for pharmaceutical industries to target a structure that is found specifically only in fungal cells such as the chitin structure [
 <xref rid="B81-molecules-26-00628" ref-type="bibr">81</xref>,
 <xref rid="B82-molecules-26-00628" ref-type="bibr">82</xref>].
</p>
